AusPAR: Certolizumab

Related information

How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

30 September 2014
AusPAR Details
AusPAR
AusPAR: Certolizumab (pdf, 2 MB)
AusPAR: Certolizumab (docx, 987 KB)
Attachment: Product Information: Cimzia (pdf, 334 KB)
Attachment: Product Information: Cimzia (docx, 183 KB)
Attachment: Extract from Clinical Evaluation Report: Certolizumab (pdf, 1 MB)
Attachment: Extract from Clinical Evaluation Report: Certolizumab (docx, 457 KB)
Active Ingredient
Certolizumab
Product Name
Cimzia
Sponsor
UCB Australia Pty Ltd
Submission Number
PM-2013-00286-2-3
Submission Type
Extension of indications
Decision
Approved
AusPAR Date
15 August 2014
Publication Date

30 September 2014
Tags: 
medicines, AusPARs
URL: 
https://www.tga.gov.au/node/190184